Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts
- PMID: 20360961
- PMCID: PMC2847913
- DOI: 10.1371/journal.pone.0009920
Setting of methods for analysis of mucosal antibodies in seminal and vaginal fluids of HIV seropositive subjects from Cambodian and Italian cohorts
Abstract
Background: Genital mucosae play a key role in protection from STD and HIV infection, due to their involvement in both horizontal and vertical disease transmission. High variability of published observations concerning IgA isolation and quantification underlies the strong requirement of specific methods able to maximize investigation on HIV-specific IgA.
Methodology: Genital fluids from 109 subjects, including male and female cohorts from Italy and Cambodia, were collected, aliquoted and processed with different techniques, to assess optimal conditions maximizing mucosal antibody recovery. Three sampling techniques, up to sixteen preservation conditions, six ELISA methods and four purifications protocols were compared.
Principal findings: The optimal method here described took advantage of Weck-Cel sampling of female mucosal fluids. Immediate processing of genital fluids, with the addition of antibiotics and EDTA, improved recovery of vaginal IgA, while the triple addition of EDTA, antibiotics and protease inhibitors provided the highest amount of seminal IgA. Due to low amount of IgA in mucosal fluids, a high sensitive sandwich ELISA assay was set; sensitivity was enhanced by milk-based overcoating buffer and by a two-step biotin-streptavidin signal amplification. Indeed, commercial antisera to detect human immunoglobulins showed weak cross-reactivity to different antibody types. Three-step affinity purification provided reproducible immunoglobulin recovery from genital specimens, while conventional immuno-affinity IgA purification was found poorly manageable. Affinity columns were suitable to isolate mucosal IgA, which are ten-fold less concentrated than IgG in genital specimens, and provided effective separation of IgA monomers, dimers, and J-chains. Jacalin-bound resin successfully separated IgA1 from IgA2 subfraction.
Conclusions/significance: Specific, effective and reliable methods to study local immunity are key items in understanding host mucosal response. The sequence of methods here described is effective and reliable in analysing humoral local responses, and may provide a solid advance to identify and measure the effective mucosal responses to HIV.
Conflict of interest statement
Figures






Similar articles
-
Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 1;15(3):185-91. doi: 10.1097/00042560-199707010-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9257652
-
IgA immunity in HIV type 1-infected chimpanzees. II. Mucosal immunity.AIDS Res Hum Retroviruses. 1997 Oct 10;13(15):1273-82. doi: 10.1089/aid.1997.13.1273. AIDS Res Hum Retroviruses. 1997. PMID: 9339844
-
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.AIDS. 1999 Jan 14;13(1):23-9. doi: 10.1097/00002030-199901140-00004. AIDS. 1999. PMID: 10207541
-
Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.Am J Reprod Immunol. 2021 Nov;86(5):e13478. doi: 10.1111/aji.13478. Epub 2021 Jun 16. Am J Reprod Immunol. 2021. PMID: 34077596 Free PMC article. Review.
-
Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Am J Reprod Immunol. 2014 Jun;71(6):600-7. doi: 10.1111/aji.12203. Epub 2014 Feb 5. Am J Reprod Immunol. 2014. PMID: 24494997 Free PMC article. Review.
Cited by
-
HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.PLoS One. 2014 Jul 23;9(7):e101863. doi: 10.1371/journal.pone.0101863. eCollection 2014. PLoS One. 2014. PMID: 25054205 Free PMC article.
-
Challenges in mucosal HIV vaccine development: lessons from non-human primate models.Viruses. 2014 Aug 15;6(8):3129-58. doi: 10.3390/v6083129. Viruses. 2014. PMID: 25196380 Free PMC article. Review.
-
A nonparametric procedure for defining a new humoral immunologic profile in a pilot study on HIV infected patients.PLoS One. 2013;8(3):e58768. doi: 10.1371/journal.pone.0058768. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533590 Free PMC article.
-
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.PLoS One. 2013;8(2):e55438. doi: 10.1371/journal.pone.0055438. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437055 Free PMC article. Clinical Trial.
-
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.AIDS. 2016 Apr 24;30(7):1005-14. doi: 10.1097/QAD.0000000000001038. AIDS. 2016. PMID: 26836790 Free PMC article.
References
-
- Quinn TaO, J. HIV/AIDS in Women: An Expanding Epidemic. Science. 2005;308:1582–1583. - PubMed
-
- Veazey RS, Marx PA, Lackner AA. The mucosal immune system: primary target for HIV infection and AIDS. Trends Immunol. 2001;22:626–633. - PubMed
-
- Lehner T. Innate and adaptive mucosal immunity in protection against HIV infection. Vaccine. 2003;21(Suppl 2):S68–76. - PubMed
-
- Barassi C, Lazzarin A, Lopalco L. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood. 2004;104:2205–2206. - PubMed
-
- Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. Aids. 2000;14:1917–1920. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous